<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This report describes 2 patients who developed <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) type M2 and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) of the FAB classification, respectively 2 months and 2 weeks after diagnosis of operable <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> showed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> 2 months before the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, had a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype, and showed a good response to chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>The patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> had a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype, and she was treated with <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> and supportive therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The 2 patients had no previous exposure to irradiation or cytotoxic therapy </plain></SENT>
<SENT sid="4" pm="."><plain>These cases show that <z:hpo ids='HP_0003002'>breast cancer</z:hpo> and either <z:hpo ids='HP_0001909'>leukemia</z:hpo> or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> may be associated even without previous irradiation or combination chemotherapy </plain></SENT>
</text></document>